Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Price to Cash Earnings (PCE)

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   PCE(x) 42.68---

What is the latest Price to Cash Earnings (PCE) ratio of CORONA REMEDIES ?

The latest Price to Cash Earnings (PCE) ratio of CORONA REMEDIES is 42.68 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202642.68
Mar2025-
Mar2024-
Mar2023-

How is Price to Cash Earnings (PCE) of CORONA REMEDIES Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 42.68
0
Mar2025 0
0
Mar2024 0
0
Mar2023 0 -

Other Financial Ratios of CORONA REMEDIES


Compare Price to Cash Earnings (PCE) ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,363.6 Cr 1.7% 2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,565.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 5.8% 3.2% -8.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

1.7%

2%

NA
SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses